The World Health Organization warned that artificial sweeteners, used to replace sugar in a vast range of products, do not help in losing weight and can have serious health effects.
According to the United Nations health agency, a systematic review of available evidence "suggests that use of non-sugar sweeteners (NSS) does not confer any long-term benefit in reducing body fat in adults or children.
In addition, results from the review suggest that the long-term use of NSS could increase the risk of type 2 diabetes, cardiovascular diseases, and mortality in adults.
The WHO's director for nutrition and food safety, Francesco Branca, stressed that replacing ordinary sugar with artificial sweeteners "does not help with weight control in the long term".
He added that NSS are not essential dietary factors and have no nutritional value.
The WHO said its new recommendation applied to everyone except individuals with pre-existing diabetes.
It includes all synthetic and naturally occurring or modified sweeteners not classified as sugars found in manufactured foods and beverages or sold on their own to be added to products by consumers.
Among the most widely used sweeteners are acesulfame K, aspartame, advantame, cyclamates, neotame, saccharin, sucralose, stevia, and stevia derivatives, it said.


RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
U.S. Stock Futures Edge Higher as Tech Rout Deepens on AI Concerns and Earnings
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance 



